Table S1. Characteristics of the studies included in the meta-analysis. Table S2. Quality of assessment for included studies. Table S3. Sensitivity analysis assessing mortality. (DOCX 24 kb
Characteristics of studies selected for inclusion in meta-analysis. This file contains descriptive i...
ST1. Sensitivity analysis results: frequencies of MRSA, MSSA, and Total SA colonization at the endpo...
Figure S1 Distribution of propensity scores post matching process. Figure S2. Plot of the first two ...
Forest plots of odds ratios for second outcomes (see in Figure S1-S8). (DOCX 11351 kb
Supplement 1. Antibiotic resistance rate of identified Staphylococcus aureus. (DOCX 21Â kb
Multivariate analysis of prognostic factors for predicting mortality in patients with MSSA bacteremi...
Figure S1. Assessment of risk of bias in included trials. Figure S2. Forrest plot based on aggregate...
Table S1. Antibiotics prescribed in the control group. Table S2. Etiology of the infected patients r...
Definitions of Clinical and Microbiologic Outcomes. Additional file 1: Table S1. defines the clinica...
Susceptibility to antimicrobial agents of MRSA isolates from patients with MRSA pneumonia ( Nâ =â...
PRISMA checklist of items to include when reporting a systematic review and a network meta-analysis....
Table S1. Source distribution of 210 strains of CRAB-BSI. Table S2. Drug resistance of A. baumannii....
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Table S1. Summary of sensitive analysis for prophylaxis efficacy. Figure S1. Source of bias in two r...
Overview of studies evaluating the impact of antimicrobial stewardship on management and outcomes of...
Characteristics of studies selected for inclusion in meta-analysis. This file contains descriptive i...
ST1. Sensitivity analysis results: frequencies of MRSA, MSSA, and Total SA colonization at the endpo...
Figure S1 Distribution of propensity scores post matching process. Figure S2. Plot of the first two ...
Forest plots of odds ratios for second outcomes (see in Figure S1-S8). (DOCX 11351 kb
Supplement 1. Antibiotic resistance rate of identified Staphylococcus aureus. (DOCX 21Â kb
Multivariate analysis of prognostic factors for predicting mortality in patients with MSSA bacteremi...
Figure S1. Assessment of risk of bias in included trials. Figure S2. Forrest plot based on aggregate...
Table S1. Antibiotics prescribed in the control group. Table S2. Etiology of the infected patients r...
Definitions of Clinical and Microbiologic Outcomes. Additional file 1: Table S1. defines the clinica...
Susceptibility to antimicrobial agents of MRSA isolates from patients with MRSA pneumonia ( Nâ =â...
PRISMA checklist of items to include when reporting a systematic review and a network meta-analysis....
Table S1. Source distribution of 210 strains of CRAB-BSI. Table S2. Drug resistance of A. baumannii....
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Table S1. Summary of sensitive analysis for prophylaxis efficacy. Figure S1. Source of bias in two r...
Overview of studies evaluating the impact of antimicrobial stewardship on management and outcomes of...
Characteristics of studies selected for inclusion in meta-analysis. This file contains descriptive i...
ST1. Sensitivity analysis results: frequencies of MRSA, MSSA, and Total SA colonization at the endpo...
Figure S1 Distribution of propensity scores post matching process. Figure S2. Plot of the first two ...